First Trust Nasdaq Pharmaceuticals ETF (FTXH) |
| 38.2399 -0.08 (-0.21%) 07-13 16:00 |
| Open: | 38.025 |
| High: | 38.31 |
| Low: | 37.985 |
| Volume: | 14,804 |
| Market Cap: | 36(M) |
| PE Ratio: | 26.53 |
| Exchange: | NASDAQ Global Market |
| Industry: | Asset Management - Global |
| Sector: | Financial Services |
| Technical analysis | ||||
 |
||||
| sell | buy | |||
| Resistance 2: | 46.22 |
| Resistance 1: | 39.57 |
| Pivot price: | 38.04 |
| Support 1: | 36.69 |
| Support 2: | 34.91 |
| 52w High: | 39.57 |
| 52w Low: | 25.765 |
The First Trust Nasdaq Pharmaceuticals ETF (FTXH) operates as an exchange-traded fund. Its primary aim is to mirror the financial performance—both capital appreciation and income generation—of the Nasdaq US Smart Pharmaceuticals Index, prior to any fund-specific fees and expenses. To achieve this, the ETF endeavors to precisely replicate the constituents and their proportionate allocations within that index, striving for a performance correlation of at least 95%.
Financials
| EPS | 0.000 |
| Book Value | 0.000 |
| PEG Ratio | 0.00 |
| Gross Profit | 0.000 |
| Profit Margin (%) | 0.00 |
| Operating Margin (%) | 0.00 |
| Return on Assets (ttm) | 0.0 |
| Return on Equity (ttm) | 0.0 |
Company news
Thu, 16 Oct 2025
ETFs to Watch Post JNJ's Q3 Earnings Surprise & Bullish Outlook - TradingView
Thu, 08 Aug 2024
LLYX Stock Fund Price and Chart — AMEX:LLYX - TradingView
Wed, 17 Apr 2024
The 5 Best Pharmaceutical ETFs of 2023 - ETF.com
Tue, 25 Jul 2023
First Trust Exchange-Traded Fund III - First Trust Nasdaq Pharmaceuticals ETF (FTXH) News, Articles, Events & Latest Updates - Stocktwits
Thu, 22 Jun 2023
Biotech ETFs in Focus on Covid Vaccines' Fall Rollout - Yahoo Finance
Thu, 02 Mar 2023
FTXH Top Holdings List & Exposure (First Trust Nasdaq Pharmaceuticals ETF) - MarketBeat
 StockChart iOS |
 StoxlineLite iOS |
StoxlineLite iOS |
 OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |
